Abstract:Percutaneous aortic valve implantation (TAVI) has become the standard treatment of severe aortic stenosis (AS) [1]. However, the major limitation of TAVI remains the phenomenon of valve degeneration and thrombosis, which may affect long-term outcomes [2-4].
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.